Shanghai Argo Biopharmaceutical Co., Ltd.

This study tests an experimental drug called BW-20805 in 25 adults with hereditary angioedema (HAE), a condition that causes sudden, painful swelling. The goal is to see if the drug can reduce how often attacks happen over about 6 months. Participants must have had at least 2 att…

This Phase 2 trial tests whether a new injection called BW-20507, combined with pegylated interferon alfa, can help people with chronic hepatitis B stop their daily antiviral medication (NUCs). About 209 adults with hepatitis B will receive the combination for 48 weeks. The main …

This study tests an investigational drug called BW-00112 in 145 adults with mixed dyslipidemia, a condition where levels of certain blood fats are too high. Participants receive injections of the drug or a placebo over several months while continuing their usual statin medication…

This early-phase trial is testing the safety and tolerability of a new drug called BW-50218 in 60 healthy adults. Participants receive a single injection of either the drug or a placebo, and researchers monitor for side effects and how the drug moves through the body. The goal is…

This Phase 1 trial is testing a single dose of an experimental drug called BW-50218 in 24 healthy Chinese adults. The main goal is to check for side effects and see how the drug moves through the body. Because it involves healthy participants, this study is not meant to treat any…